| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Opus Genetics, Inc. (IRD) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 7 sells. IRD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.79M | $14.11M | - | |
| ? | 1.99M | $7.41M | - | |
| CEO | 1.73M | $6.44M | -9,475 | |
| Pres | 704.1K | $2.62M | -7,429 | |
| CFO | 584.4K | $2.17M | -7,783 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2019 | Price Ben Gil | Director | Buy | 15,000 | $0.61 | $9,141.00 | New | |
| Apr 10, 2017 | Ahn Chang Ho | Director | Sale+OE | 250,000 | $0.70 | $175,375.00 | -4.0% | |
| Jan 12, 2015 | Ahn Chang Ho | Director | Sale+OE | 314,656 | $0.91 | $286,772.37 | -1.7% | |
| Jan 12, 2015 | Jeong Tae Heum | Chief Financial Officer | Sale+OE | 317,272 | $0.91 | $289,135.57 | -17.3% |